NCT03398148 · Interventional trial
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Overall registry status Completed
Phase 2 · Phase 3
Conditions Ulcerative Colitis (UC)
Delaware Valley sites
- University of Pennsylvania /ID# 166266 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory